BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22146617)

  • 1. High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?
    Nieto Y; Shpall EJ
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):3-5. PubMed ID: 22146617
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells.
    Müller AM; Kohrt HE; Cha S; Laport G; Klein J; Guardino AE; Johnston LJ; Stockerl-Goldstein KE; Hanania E; Juttner C; Blume KG; Negrin RS; Weissman IL; Shizuru JA
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):125-33. PubMed ID: 21767515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?
    Cheng YC; Ueno NT
    Womens Health (Lond); 2010 Jul; 6(4):481-5. PubMed ID: 20597609
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
    Pedrazzoli P; Bianchi AS; Renga M; Siena S
    J Natl Cancer Inst; 2000 Aug; 92(15):1271-2. PubMed ID: 10922417
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.
    Koç ON; Gerson SL; Cooper BW; Dyhouse SM; Haynesworth SE; Caplan AI; Lazarus HM
    J Clin Oncol; 2000 Jan; 18(2):307-16. PubMed ID: 10637244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy with autologous stem cell support in patients with breast cancer.
    Rahman ZU; Hortobagyi GN; Buzdar AU; Champlin R
    Cancer Treat Rev; 1998 Aug; 24(4):249-63. PubMed ID: 9805506
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
    Demirer T; Buckner CD; Appelbaum FR; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger WI
    Bone Marrow Transplant; 1996 May; 17(5):769-74. PubMed ID: 8733696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH
    N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?
    Ener RA; Meglathery SB; Cuhaci B; Topolsky D; Styler MJ; Crilley P; Brodsky I; Kahn SB; King RS
    Am J Clin Oncol; 2001 Feb; 24(1):19-25. PubMed ID: 11232944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy.
    Moore HC; Mick R; Solin LJ; Sickles C; Mangan PA; Luger SM; Fox KR; Schuchter LM; Loh E; Porter DL; Schuster S; Buzby GP; Glatstein E; Silberstein LE; Stadtmauer EA
    Ann Oncol; 1999 Aug; 10(8):929-36. PubMed ID: 10509154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 12. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
    Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L
    Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.
    Tallman MS; Gray R; Robert NJ; LeMaistre CF; Osborne CK; Vaughan WP; Gradishar WJ; Pisansky TM; Fetting J; Paietta E; Lazarus HM
    N Engl J Med; 2003 Jul; 349(1):17-26. PubMed ID: 12840088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
    Wong R; Rondon G; Saliba RM; Shannon VR; Giralt SA; Champlin RE; Ueno NT
    Bone Marrow Transplant; 2003 Jun; 31(12):1157-63. PubMed ID: 12796796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.
    Berry DA; Ueno NT; Johnson MM; Lei X; Caputo J; Smith DA; Yancey LJ; Crump M; Stadtmauer EA; Biron P; Crown JP; Schmid P; Lotz JP; Rosti G; Bregni M; Demirer T
    J Clin Oncol; 2011 Aug; 29(24):3224-31. PubMed ID: 21768454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive cyclic chemotherapy and transplantation of autologous peripheral blood progenitor cells (PBPC) or whole blood in high-risk breast cancer - follow up at 10 years.
    Cinek P; Filip S; Vanasek J; Mericka P; Blaha M; Zouhar M
    Exp Oncol; 2007 Jun; 29(2):144-51. PubMed ID: 17704748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.
    Martino M; Ballestrero A; Zambelli A; Secondino S; Aieta M; Bengala C; Liberati AM; Zamagni C; Musso M; Aglietta M; Schiavo R; Castagna L; Rosti G; Bruno B; Pedrazzoli P
    Bone Marrow Transplant; 2013 Mar; 48(3):414-8. PubMed ID: 22863724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Much ado about not...enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer.
    Zujewski J; Nelson A; Abrams J
    J Natl Cancer Inst; 1998 Feb; 90(3):200-9. PubMed ID: 9462677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer.
    Kröger N; Frick M; Gluz O; Mohrmann S; Metzner B; Jackisch C; Ko Y; Lindemann HW; Meier CR; Lohrmann HP; Ruffert U; Hänel M; Bodenstein H; Neubauer A; Ehninger G; Wolf HH; Kolbe K; Burock K; Zander AR; Nitz U
    J Clin Oncol; 2006 Aug; 24(24):3919-26. PubMed ID: 16921043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.